Tus kws kho mob
QP59-20 MHCP Pharmacy Benefit Exclusion for DurystaTM and Fensolvi®
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 08, 2020
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1971 - 1980 ntawm 4269
Tus kws kho mob
QP60-20 Commercial Pharmacy Benefit Exclusion for Procysbi® Delayed-Release Granules
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 08, 2020
Tus kws kho mob
P51-20 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 01, 2020
Tus kws kho mob
P47-20 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective August 31, 2020
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 01, 2020
Tus kws kho mob
P50-20 eviCore is Changing Prior Authorization Guidelines used to Review Durable Medical Equipment (DME), Home Health Care (HHC), and Post-Acute Care (PAC) Services for Medicare Advantage Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 01, 2020
Tus kws kho mob
P49-20 CERiS Review of High Dollar Claims
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 01, 2020
Tus kws kho mob
QP52-20 Claim Submission Requirements for Lab Services
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 10, 2020
Tus kws kho mob
QP55-20 Housing Stabilization Services – New MHCP Benefit
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 24, 2020
Tus kws kho mob
QP31R1-20 Update: Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Oxbryta™
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 24, 2020